Masong, Baby Girl .
HRN: 21-94-52 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/17/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
09/17/2022
09/24/2022
IV
36mg
Q24h
Potentially Septic Newborn (Thinly Msaf)
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes